Delivery Order SPE2DB20D2002-SPE2DB24FL87E

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,317.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,562,181,703 units of Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite...
This federal contract award is for the delivery of 4,559,457,678 units of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,573.55 fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,425.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of 4,564,007,468 units of Oseltamivir Phosphate 75mg capsules. The contract has an ultimate completion date of March 20, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen, a for-profit...
This federal contract award, valued at $12,975.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,559,450,627 units of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The contract has an ultimate completion date of December 27, 2022 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through...
This federal contract award, valued at $2,093.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,491,555 units of Oseltamivir Phosphate 75mg capsules. It is a firm-fixed-price Delivery Order contract with a completion date of January 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $10,623.96, is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,074,564 units of oseltamivir phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,779.47 and a completion date of January 29, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,035.78 firm fixed-price delivery order contract is for the supply of 4,562,562,995 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. This appears to be a task order under a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $1,853.16 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,241.74, is for the delivery of 4,567,154,184 units of Oseltamivir Phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 5, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL87E
    Delivery Order

This federal contract award, valued at $1,329.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of 4,565,784,218 units of Oseltamivir Phosphate 75 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 13, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award was not designated with a set-aside requirement, indicating open competition. No subcontractors were identified in the provided information.

Generated 2/27/25, 12:22 PM